Fosnetupitant is a medication used for the treatment of chemotherapy-induced nausea and vomiting. It is a prodrug of netupitant.[1] It is used in combination with palonosetron hydrochloride and formulated as the salt fosnetupitant chloride hydrochloride for intravenous use.[2]
In 2018, the US Food and Drug Administration approved the intravenous formulation of a fixed dose combination of fosnetupitant and palonosetron.[3][4] The combination is also approved for medical use in the European Union[5] and in Canada.[6]
^Aapro M, Jordan K, Scotté F, Celio L, Karthaus M, Roeland E (2022). "Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily Practice". Current Cancer Drug Targets. 22 (10): 806–824. doi:10.2174/1568009622666220513094352. PMC 9720881. PMID 35570542.
^"Fosnetupitant/Palonosetron (Intravenous Route)". Mayo Clinic. Archived from the original on June 8, 2022. Retrieved June 8, 2022.
^"Fosnetupitant". DrugBank. Archived from the original on December 2, 2021. Retrieved June 8, 2022.
^"Akynzeo- netupitant and palonosetron capsule Akynzeo- fosnetupitant and palonosetron injection". DailyMed. 28 May 2020. Archived from the original on 18 October 2020. Retrieved 18 July 2020.
^"Akynzeo EPAR". European Medicines Agency (EMA). Archived from the original on 19 March 2020. Retrieved 9 June 2022.
^"Akynzeo (netupitant/palonosetron) capsules" (PDF). Product Insert. Elvium Life Sciences. 31 August 2020. Archived (PDF) from the original on 2022-06-10. Retrieved 2022-06-10.
Fosnetupitant is a medication used for the treatment of chemotherapy-induced nausea and vomiting. It is a prodrug of netupitant. It is used in combination...
States, the combinations of netupitant/palonosetron and the prodrug fosnetupitant/palonosetron (both brand name Akynzeo) are approved by the Food and...
January 2022. "Akynzeo- netupitant and palonosetron capsule Akynzeo- fosnetupitant and palonosetron injection". DailyMed. Archived from the original on...
Global Information
